These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28714190)

  • 1. Polymorphisms of xenobiotic-metabolizing genes and colorectal cancer risk in patients with lynch syndrome: A retrospective cohort study in Taiwan.
    Kamiza AB; You JF; Wang WC; Tang R; Chang CY; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Hsiung CA; Yeh CC
    Environ Mol Mutagen; 2018 Jan; 59(1):69-78. PubMed ID: 28714190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
    Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
    PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.
    Pande M; Amos CI; Osterwisch DR; Chen J; Lynch PM; Broaddus R; Frazier ML
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2393-401. PubMed ID: 18768509
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kamiza AB; Wang WC; You JF; Tang R; Wang YT; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Hsiung CA; Yeh CC
    Anticancer Res; 2018 Oct; 38(10):5983-5990. PubMed ID: 30275229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence Polymorphism in Xenobiotic Metabolising Genes in Iraqi Colorectal Cancer Patients.
    Ibrahem SQ; Al-Dalawi ZT; Bahaaldin AS
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1203-1210. PubMed ID: 33906313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
    Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Cancer Epidemiol; 2012 Apr; 36(2):183-9. PubMed ID: 21974800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNP association study in PMS2-associated Lynch syndrome.
    Ten Broeke SW; Elsayed FA; Pagan L; Olderode-Berends MJW; Garcia EG; Gille HJP; van Hest LP; Letteboer TGW; van der Kolk LE; Mensenkamp AR; van Os TA; Spruijt L; Redeker BJW; Suerink M; Vos YJ; Wagner A; Wijnen JT; Steyerberg EW; Tops CMJ; van Wezel T; Nielsen M
    Fam Cancer; 2018 Oct; 17(4):507-515. PubMed ID: 29147930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.
    Talseth-Palmer BA; Brenne IS; Ashton KA; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Lubinski J; Scott RJ
    J Med Genet; 2011 Apr; 48(4):279-84. PubMed ID: 21097774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of DNA repair genes are associated with colorectal cancer in patients with Lynch syndrome.
    Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
    Mol Genet Genomic Med; 2018 Apr; 6(4):533-40. PubMed ID: 29664240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
    Wijnen JT; Brohet RM; van Eijk R; Jagmohan-Changur S; Middeldorp A; Tops CM; van Puijenbroek M; Ausems MG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Verhoef S; Wagner A; Nagengast FM; Kleibeuker JH; Devilee P; Morreau H; Goldgar D; Tomlinson IP; Houlston RS; van Wezel T; Vasen HF
    Gastroenterology; 2009 Jan; 136(1):131-7. PubMed ID: 19010329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations in the xenobiotic-metabolizing enzymes CYP1A1, CYP1A2, CYP2C9, CYP2C19 and susceptibility to colorectal cancer among Turkish people.
    Özhan G; Mutur M; Ercan G; Alpertunga B
    Genet Test Mol Biomarkers; 2014 Apr; 18(4):223-8. PubMed ID: 24527758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome.
    Sotamaa K; Liyanarachchi S; Mecklin JP; Järvinen H; Aaltonen LA; Peltomäki P; de la Chapelle A
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6840-4. PubMed ID: 16203772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.
    Reeves SG; Meldrum C; Groombridge C; Spigelman AD; Suchy J; Kurzawski G; Lubinski J; McElduff P; Scott RJ
    Eur J Hum Genet; 2009 May; 17(5):629-35. PubMed ID: 19156174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 17A1 and catechol O-methyltransferase polymorphisms and age at Lynch syndrome colon cancer onset in Newfoundland.
    Campbell PT; Edwards L; McLaughlin JR; Green J; Younghusband HB; Woods MO
    Clin Cancer Res; 2007 Jul; 13(13):3783-8. PubMed ID: 17606708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
    Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
    Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
    Sun K; Gong A; Liang P
    Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility genetic variants associated with early-onset colorectal cancer.
    Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
    Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.